Title:
The combined use tablet which has exo Zoom and corticosteroid
Document Type and Number:
Japanese Patent JP5907886
Kind Code:
B2
Abstract:
The present invention relates to pharmaceutical compositions for a combination therapy with a corticosteroid and exosomes. By means of the combination therapy diseases such as osteoarthritis, arthritis and/or degenerative spinal diseases can be treated.
Inventors:
Peter Wehring
Yurio Reineke
Yurio Reineke
Application Number:
JP2012542570A
Publication Date:
April 26, 2016
Filing Date:
December 10, 2010
Export Citation:
Assignee:
ORTHOGEN Aktiengesellschaft
International Classes:
A61K31/573; A61K35/14; A61K35/15; A61K35/19; A61K38/00; A61K39/395; A61P17/00; A61P19/02
Domestic Patent References:
| JP2008505104A | ||||
| JP2005290009A | ||||
| JP2007267741A |
Other References:
BRESNIHAN BARRY,TREATMENT OF RHEUMATOID ARTHRITIS WITH RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST,ARTHRITIS & RHEUMATISM,1998年12月,V41 N12,P2196-2204
SETTAS LUCAS D,REACTIVATION OF PULMONARY TUBERCULOSIS IN A PATIENT WITH RHEUMATOID ARTHRITIS 以下備考,JOURNAL OF CLINICAL RHEUMATOLOGY,2007年 8月,V13 N4,P219-220,DURING TREATMENT WITH IL-1 RECEPTOR ANTAGONISTS (ANAKINRA)
BIANCO NICOLE R,THERAPEUTIC EFFECT OF EXOSOMES FROM INDOLEAMINE 2,3-DIOXYGENASE-POSITIVE 以下備考,ARTHRITIS & RHEUMATISM,2009年 2月,V60 N2,P380-389,DENDRITIC CELLS IN COLLAGEN-INDUCED ARTHRITIS AND DELAYED-TYPE HYPERSENSITIVITY DISEASE MODELS
SETTAS LUCAS D,REACTIVATION OF PULMONARY TUBERCULOSIS IN A PATIENT WITH RHEUMATOID ARTHRITIS 以下備考,JOURNAL OF CLINICAL RHEUMATOLOGY,2007年 8月,V13 N4,P219-220,DURING TREATMENT WITH IL-1 RECEPTOR ANTAGONISTS (ANAKINRA)
BIANCO NICOLE R,THERAPEUTIC EFFECT OF EXOSOMES FROM INDOLEAMINE 2,3-DIOXYGENASE-POSITIVE 以下備考,ARTHRITIS & RHEUMATISM,2009年 2月,V60 N2,P380-389,DENDRITIC CELLS IN COLLAGEN-INDUCED ARTHRITIS AND DELAYED-TYPE HYPERSENSITIVITY DISEASE MODELS
Attorney, Agent or Firm:
Einzel Felix-Reinhard
Junichi Maekawa
Hiroyasu Ninomiya
Ueshima
Junichi Maekawa
Hiroyasu Ninomiya
Ueshima